107 related articles for article (PubMed ID: 28645682)
21. Perspectives on diabetes mortality as the result of residual confounding and reverse causality by common disease.
Thuesen ACB; Vaag A
Diabetes Obes Metab; 2018 Jun; 20(6):1342-1349. PubMed ID: 29381250
[TBL] [Abstract][Full Text] [Related]
22. [Incidence, risk profile and mortality rate of a sample of type II diabetic patients with albuminuria in general practice. A 3-year prospective follow-up study].
Stiegler H; Standl R; Mathies R; Standl E; Mehnert H; Roth R; Schulz K; Lehmacher W
Vasa Suppl; 1991; 32():274-8. PubMed ID: 1771514
[No Abstract] [Full Text] [Related]
23. [More harmful in diabetics].
Springer Medizin
MMW Fortschr Med; 2016 Mar; 158(5):3. PubMed ID: 26979183
[No Abstract] [Full Text] [Related]
24. Subclinical hypothyroidism and mortality in a large Austrian cohort: a possible impact on treatment?
Kovar FM; Fang IF; Perkmann T; Haslacher H; Slavka G; Födinger M; Endler G; Wagner OF
Wien Klin Wochenschr; 2015 Dec; 127(23-24):924-30. PubMed ID: 26373750
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of depression and mortality in patients with type 2 diabetes: the Fremantle Diabetes Study.
Bruce DG; Davis WA; Starkstein SE; Davis TM
Diabetologia; 2005 Dec; 48(12):2532-9. PubMed ID: 16292463
[TBL] [Abstract][Full Text] [Related]
26. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women: response to Juutilainen et al.
Targher G; Bertolini L; Zoppini G; Lippi G; Zenari L
Diabetes Care; 2007 Jun; 30(6):e51; author reply e52. PubMed ID: 17526813
[No Abstract] [Full Text] [Related]
27. Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.
Rådholm K; Chalmers J; Ohkuma T; Peters S; Poulter N; Hamet P; Harrap S; Woodward M
Diabetes Obes Metab; 2018 Aug; 20(8):1903-1910. PubMed ID: 29603537
[TBL] [Abstract][Full Text] [Related]
28. Effect of Intensive Versus Standard Blood Glucose Control in Patients With Type 2 Diabetes Mellitus in Different Regions of the World: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Sardar P; Udell JA; Chatterjee S; Bansilal S; Mukherjee D; Farkouh ME
J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25944874
[TBL] [Abstract][Full Text] [Related]
29. Lipoprotein(a) as a risk factor for cardiovascular mortality in type 2 diabetic patients: a 10-year follow-up study.
Hernández C; Francisco G; Chacón P; Simó R
Diabetes Care; 2005 Apr; 28(4):931-3. PubMed ID: 15793200
[No Abstract] [Full Text] [Related]
30. Fibrinogen and AER are major independent predictors of 11-year cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study.
Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo-Perin P;
Diabetologia; 2005 Mar; 48(3):427-34. PubMed ID: 15696295
[TBL] [Abstract][Full Text] [Related]
31. Diabetes and number of years of life lost with and without cardiovascular disease: a multi-state homogeneous semi-Markov model.
Ramezankhani A; Azizi F; Hadaegh F; Momenan AA
Acta Diabetol; 2018 Mar; 55(3):253-262. PubMed ID: 29299678
[TBL] [Abstract][Full Text] [Related]
32. Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes.
Clarke PM; Hayes AJ; Glasziou PG; Scott R; Simes J; Keech AC
Med Care; 2009 Jan; 47(1):61-8. PubMed ID: 19106732
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of excess cardiovascular mortality in diabetes.
Keen H; Ashton CE
Postgrad Med J; 1989; 65 Suppl 1():S26-9. PubMed ID: 2695907
[No Abstract] [Full Text] [Related]
34. The global burden of diabetes and its complications: an emerging pandemic.
van Dieren S; Beulens JW; van der Schouw YT; Grobbee DE; Neal B
Eur J Cardiovasc Prev Rehabil; 2010 May; 17 Suppl 1():S3-8. PubMed ID: 20489418
[TBL] [Abstract][Full Text] [Related]
35. Orthostatic hypotension in diabetic patients-10-year follow-up study.
Gaspar L; Kruzliak P; Komornikova A; Celecova Z; Krahulec B; Balaz D; Sabaka P; Caprnda M; Kucera M; Rodrigo L; Uehara Y; Dukat A
J Diabetes Complications; 2016; 30(1):67-71. PubMed ID: 26412028
[TBL] [Abstract][Full Text] [Related]
36. Interplay of diabetes and coronary heart disease on cardiovascular mortality.
Boccara F; Cohen A
Heart; 2004 Dec; 90(12):1371-3. PubMed ID: 15547003
[TBL] [Abstract][Full Text] [Related]
37. Optimizing care in diabetes: a quixotic challenge.
Friedman EA
Diabetes Care; 2012 Jun; 35(6):1204-5. PubMed ID: 22619287
[No Abstract] [Full Text] [Related]
38. Hard end points are needed for intensive glycaemic control in patients with type 2 diabetes.
Yudkin JS; Lipska KJ
BMJ; 2012 Jan; 344():e708; author reply e710. PubMed ID: 22293372
[No Abstract] [Full Text] [Related]
39. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
[TBL] [Abstract][Full Text] [Related]
40. Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria.
von Scholten BJ; Reinhard H; Hansen TW; Schalkwijk CG; Stehouwer C; Parving HH; Jacobsen PK; Rossing P
J Diabetes Complications; 2016 Mar; 30(2):248-55. PubMed ID: 26651261
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
